PTEN and cancer: In addition, in other cancers, including oral squamous cell carcinoma, exosomal miR-21 derived from tumor cells activates the downstream pathway PTEN-PD-L1 in myeloid-derived suppressor cells (MDSCs), which further improves immune tolerance in the TME [11].